Expanding Diagnostic Options for Pediatric Meningitis: BCID2 Testing Results on Cerebrospinal Fluid After a Negative Meningitis/Encephalitis Panel
Antibiotics · 21.05.2026 · 15 (5) · 519
DOI: 10.3390/antibiotics15050519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 21.05.2026. Verfasst von Venere Cortazzo und 18 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Diagnostic Immunology Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU, ANIA, Italian Ministry of Health.
Abstract (Originalsprache)
Background
Rapid etiological diagnosis of bacterial meningitis is crucial in children, as delays can lead to neurological sequelae. The BioFire FilmArray Meningitis/Encephalitis (ME) panel is widely used on cerebrospinal fluid (CSF), but its target spectrum may miss healthcare-associated or multidrug-resistant pathogens. We evaluated the diagnostic performance and stewardship-oriented clinical impact of off-label BioFire FilmArray Blood Culture Identification 2 (BCID2) testing on CSF from pediatric patients with suspected bacterial CNS infection and negative ME results.
Methods
We retrospectively analyzed CSF samples collected between January 2023 and March 2025 at a tertiary pediatric hospital. In ME-negative cases with persistent suspicion and abnormal CSF parameters, BCID2 was performed off-label on residual CSF aliquots after routine testing, without additional sampling. We assessed pathogen detection, agreement with culture, resistance-gene identification, and documented stewardship actions.
Results
Among 76 ME-negative CSF samples tested with BCID2, 23 (30.3%) were positive, all involving organisms not included in the ME panel. BCID2 was concordant with culture in 19/23 cases (82.6%); 4/23 (17.4%) were BCID2-positive/culture-negative, consistent with reduced culture sensitivity in frequently pretreated cases. Resistance genes (VIM, vanA/B, CTX-M) were detected in 30.4% of BCID2-positive samples. Overall agreement with culture was 94.7% (PPA 100%, NPA 93.0%). Escalation was documented in 13/23 episodes (56.5%), discontinuation in 2/23 (8.7%), and confirmation in 9/23 (39.1%), with no de-escalation events; clinical outcomes were not systematically available.
Conclusions
In selected ME-negative pediatric cases with abnormal CSF profiles, BCID2 testing on residual CSF provided rapid, clinically meaningful microbiological information that may support antimicrobial optimization.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microbiology and Diagnostic Immunology Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
- Infectious Disease Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
- Multimodal Laboratory Medicine, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
- Paediatrics Clinical Unit, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
- Medical Direction, Bambino Gesù Children's Hospital, IRCCS, 00165 Rome, Italy.
ORCID-Profile: Venere Cortazzo, Lorenza Romani, Gianluca Vrenna, Maia De Luca, Marilena Agosta, Martina Rossitto, Valeria Fox, Stefania Mercadante, Stefania Bernardi, Mara Pisani, Alessandra Salvatori, Alberto Villani
Förderung
- EU
- ANIA
- Italian Ministry of Health
Zitieren
APA
Cortazzo, V., Romani, L., Vrenna, G., Luca, M., Agosta, M., Rossitto, M., Fox, V., Lucignano, B., Onori, M., Mercadante, S., Tommaso, V., Lancella, L., Bernardi, S., Pisani, M., Salvatori, A., Villani, A., Raponi, M., Perno, C. F., & Bernaschi, P. (2026). Expanding Diagnostic Options for Pediatric Meningitis: BCID2 Testing Results on Cerebrospinal Fluid After a Negative Meningitis/Encephalitis Panel. Antibiotics, 15(5), 519. https://doi.org/10.3390/antibiotics15050519
Vancouver
Cortazzo V, Romani L, Vrenna G, Luca M, Agosta M, Rossitto M, et al. Expanding Diagnostic Options for Pediatric Meningitis: BCID2 Testing Results on Cerebrospinal Fluid After a Negative Meningitis/Encephalitis Panel. Antibiotics. 2026;15(5):519. doi:10.3390/antibiotics15050519
BibTeX
@article{Cortazzo2026,
author = {Cortazzo, Venere and Romani, Lorenza and Vrenna, Gianluca and Luca, Maia De and Agosta, Marilena and Rossitto, Martina and Fox, Valeria and Lucignano, Barbara and Onori, Manuela and Mercadante, Stefania and Tommaso, Vito and Lancella, Laura and Bernardi, Stefania and Pisani, Mara and Salvatori, Alessandra and Villani, Alberto and Raponi, Massimiliano and Perno, Carlo Federico and Bernaschi, Paola},
title = {Expanding Diagnostic Options for Pediatric Meningitis: BCID2 Testing Results on Cerebrospinal Fluid After a Negative Meningitis/Encephalitis Panel},
journal = {Antibiotics},
year = {2026},
volume = {15},
number = {5},
pages = {519},
doi = {10.3390/antibiotics15050519}
}
EUVIMED